PharmAla Announces Private Placement PharmAla announces private placement financing

USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE:...